Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05324891Phase 2Completed
Phase 2, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Mansoura University. Primary endpoint: Efficacy of postoperative sedation according to pain score up to 5 days. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05324891.